| |
INFORMATION FOR CONTRIBUTORS
Manuscripts submitted to UROLOGY will receive a timely review
and authors will be notified within one month of receipt of manuscript (45 days for Basic Science) whether their work is accepted, rejected,
or requires revision. Accepted manuscripts will be published within six months of the date of final acceptance (except where noted otherwise)
provided all production materials have been delivered to the Editorial Office. Submit manuscripts to the UROLOGY Editorial Office
via the Elsevier Editorial system (EES) website for this journal; go to http://www.goldjournal.net and select "Submit Manuscript". All
correspondence regarding submitted manuscripts will be handled via e-mail through EES. Send all other correspondence to:
Eric Klein,
MD
Editor-in-Chief, UROLOGY
9500 Euclid Ave, Desk A100
Cleveland, OH 44195
Phone: 216-445-6664/216-445-9738 (Editorial
Office)
Fax: 216-636-5104
E-mail: goldjournal@ccf.org
UROLOGY publishes the following types of
articles:
1. AMBULATORY and OFFICE UROLOGY: This section features manuscripts
relating to the innovative practice of office urology
and advances in ambulatory surgery, as well as socioeconomic issues important to the practicing urologist.
2. AUTHOR REPLY (TO
EDITORIAL COMMENT) is solicited by the Editor and should not be submitted without prior invitation.
3. BASIC and TRANSLATIONAL SCIENCE:
This section will focus on original basic and translational science work related to all aspects of urology.
4. BOOK REVIEW: These
are solicited by the Editor, will go through the peer review process, and will cover recently published books in the field of Urology.
5. COMMENTARY: A mini-review article that highlights the importance of a particular topic and provides recently published supporting
data.
6. EDITORIAL COMMENTS: are solicited by the Editor and should not be submitted without prior invitation.
7. ENDOUROLOGY
and STONES: This section features manuscripts relating to endourologic approaches to the diagnosis of stones and other urologic diseases.
8. FEMALE UROLOGY: This section will focus on original work on all aspects of female urology.
9. GRAND ROUNDS: This section,
which is solicited by the Editor, will incorporate the format of Grand Rounds at most hospitals throughout the world where an interesting
case is presented, most often with radiologic, surgical and pathologic findings, followed by a discussion. Medical students, residents,
fellows and junior faculty are particularly encouraged to prepare submissions to this new section in UROLOGY. In addition, a
senior person from the institution will be required to submit an accompanying discussion concerning diagnosis and management, as would
be the case at regular hospital grand rounds. When appropriate, an editorial comment may be added by the editors.
10. HEALTH
OUTCOMES RESEARCH: This section features manuscripts relating to all aspects of research in health outcomes for urology related procedures,
treatments, diseases, and conditions.
11. IMAGES IN CLINICAL UROLOGY: Concise, one-page pictorial description of a unique case.
12. INFECTIOUS DISEASES: This section will feature manuscripts relating to infectious diseases in all areas of urology.
13.
INFERTILITY: This section will focus on original work on all aspects of male and/or female infertility.
14. LETTER-FROM-THE-EDITOR:
Periodic messages from the Editor on timely topics.
15. LAPAROSCOPY and ROBOTICS: This section features manuscripts relating to laparoscopic and robotic surgery for all urologic diseases.
16. LETTERS-TO-THE-EDITOR: Short communications regarding recent articles
or comments on timely topics in letter form that should be supported by relevant references. Authors of the cited article will have the
opportunity to read and reply to the letter. All LETTERS TO THE EDITOR must be submitted within one month of the publishing date of the
cited article. Letters if accepted will be published as space permits.
17. MALE SEXUAL DYSFUNCTION: This section will focus on original
work related to male sexual dysfunction including erectile dysfunction, peyronie's disease, priapism, and ejaculatory dysfunction.
18. MEDICAL ONCOLOGY: This section features original work relating to non-surgical aspects of urologic malignancies.
19. ONCOLOGY:
This section will highlight articles relating to diagnosis and surgical management of urologic cancers.
20. PEDIATRIC CASE REPORTS:
Unique cases demonstrating concepts of diagnosis and management in children that are relevant to the practicing urologist. Accepted
manuscripts will be published in their entirety electronically at  http://www.goldjournal.net and also in the print edition.
21. PEDIATRIC UROLOGY: This section will feature original work relating to all aspects of pediatric urology.
22. POINT- COUNTERPOINT:
This section is solicited by the Editor and will present opposite points of view on current topics in all aspects of urology related
to diagnosis, treatment, and management.
23. PROSTATIC DISEASES AND MALE VOIDING DYSFUNCTION: This section will feature original
work relating to all aspects of prostatic diseases (NOTE: Articles dealing with the diagnosis or treatment of prostate cancer should
be submitted to the "Oncology" section)
24. RAPID COMMUNICATION: Manuscripts that are extremely timely, of utmost importance, and
which the Editor deems warrant rapid publication. Two expert consultants will review these manuscripts within 48 hours and the authors
will receive notification of the status within 72 hours. The manuscript will be published in the next available issue of UROLOGY.
The submission/processing fee for a Rapid Communication Article is $300. Payment may be made via credit card or check (please
make checks payable to: Elsevier). Payment must be received prior to beginning the review process. Manuscripts that the Editorial Board
believes do not warrant rapid communication will have the submission fee returned and the authors may choose to have the manuscript continue
with the standard 30-day UROLOGY review process. Manuscripts processed as a Rapid Communication that are not found acceptable
for publication will NOT have the submission fee returned. Please note that this opportunity is for RAPID COMMUNICATION of important
timely findings and does not represent a means to obtain a RAPID REVIEW.
25. RECONSTRUCTIVE UROLOGY: This section features articles
relating to all aspects of reconstructive urology, including urinary diversion and undiversion, bladder augmentation, and urethral and
penile surgery and reconstruction.
26. REVIEW ARTICLE: This is a comprehensive article that covers timely urologic topics of clinical
relevance and must be well referenced. These articles should serve as a source for the practicing urologist and resident-in-training
of current information on a clinically useful subject. REVIEW ARTICLES are solicited by the Editor and should not be submitted without
prior written approval.
27. SUPPLEMENT ARTICLE: These articles are solicited by the Editor for a special supplement issue of Urology.
28. SURGEON'S WORKSHOP: Short, concise articles plus photos and/or drawings on "how I do it" techniques.
29. SURGICAL TECHNIQUES
IN UROLOGY: This section should represent clear descriptions of complex surgical procedures with excellent pictorial illustration.
30.
TECHNOLOGY and ENGINEERING: This section will feature original work relating to the technical aspects of a cutting edge technology or
reports the initial laboratory or clinical experience with a strong technology or engineering emphasis.
31. UPDATE: This shorter
review-type article covers current urologic topics of clinical relevance. These articles serve as an update of current information on
a clinically useful subject. UPDATES are solicited by the Editor and should not be submitted without prior written approval.
EDITORIAL
PROCESS
Peer Review: Manuscripts will be reviewed by internationally recognized experts on the subject. When relevant,
a biostatistician, radiologist, or pathologist consultant will also review the manuscript. The reviewers will be blinded to the names
of the authors and the institution from which the manuscripts have been sent.
Conflict of Interest: All authors of accepted
articles must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or
is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with
those mentioned in their manuscript. The Editor will discuss with the authors on an individual basis the method by which any conflicts
of interest will be communicated to the readers.
Authorship: Authorship should be finalized during the submission process.
Please ensure that all authors are listed and in the correct order, because changes are not permissible once the accepted manuscript
goes into production.
SUBMISSION PROCESS
Manuscripts must be submitted via the Elsevier Editorial System (EES) website
for this journal, go to http://www.goldjournal.net and select "Submit Manuscript". You will be guided stepwise through
the creation and uploading of the various files and data. Once the uploading is done, the system automatically generates an electronic
(PDF) proof, which is then used for reviewing. All correspondence regarding submitted manuscripts will be handled via e-mail through
EES. The article must be typed in 12-point type, double-spaced with one-inch margins with all pages numbered consecutively. The file
should follow the general instructions on style/arrangement, and, in particular, the reference style. The file should use the wrap-around
end-of-line feature, i.e., returns at the end of paragraphs only. Place two returns after every element, such as title, headings, paragraph.
The Title page must contain the complete list of authors, the corresponding author with his/her contact information, the word counts
for the Abstract and for the manuscript text (do not include references or figure legends); and a list of 4-6 key words. Unless specifically
indicated in the various categories listed, each manuscript should contain an Abstract and Introduction, Material and Methods, Results,
Comment, and Conclusions sections. Structured Abstracts should be 250 words or less and divided into four sections with the subheadings:
(1) Objectives, (2) Methods, (3) Results, and (4) Conclusions. Using lower-case superscript letters, link each author with the appropriate
affiliation. Manuscripts with incorrect format or that are over maximum length will be returned unreviewed for modifications (see table
for correct format/length).
Tables: Tables should supplement, not duplicate the text/figures. The tables must be numbered
and cited in order as they first appear in text, and each must have a precise heading. Please use an Arial font for the tables
in a 12-ponit size.
Illustrations: Color figures are welcomed, and will appear in color on the web at no extra charge;
however, there is a charge for the reproduction of color illustrations in print ($650 for the first color figure and $100 for
each additional color figure). Alternatively, the illustrations can be reproduced in print in black and white at no extra charge. All
illustrations must supplement, not duplicate the tables/text. Figures must clearly convey their message and be of high quality
and of sufficient size and clarity (especially lettering, arrows, and data points) to be interpretable when reduced for publication.
Shading does not always reproduce well. Consider using widely spaced cross-hatching patterns, for example, that will remain distinct
on reduction. Use black or white arrows, depending on the background color. Please use an Arial font in a 12-point size for all text
contained within the figures. All illustrations must be numbered and cited in order as they first appear in text. Concise legends
(typed on a separate page in Arial font) must accompany each illustration. If you elect to have your illustrations published in black
and white, please be sure that each figure legend DOES NOT mention colors. Do not embed artwork with text; illustrations should
be supplied as separate files. Guidelines for submitting your illustrations in an electronic format can be found at http://www.ees.elsevier.com/url/
Video/Computer Graphics: UROLOGY will not edit any video or computer graphics, but reviewers, following the usual
policy with illustrations, may suggest changes in the video or computer graphic. A sound track is highly recommended. Maximum cumulative
length of videos or computer graphics is 8 minutes, and may be divided into several smaller clips not to exceed 8 minutes in total. If
the video or animation is divided into several clips, each clip should be identified at the beginning of the section, e.g., Video Clip
1 or Graphic 1, and each clip or graphic should be saved as a separate file. Files should not exceed 30 MB each but can be split into
pieces (Part A, Part B, etc.). Concise legends (typed on a separate page) must accompany each video clip or computer graphic presentation.
The following formats for video will be accepted: MPEG-1 or MPEG-2 (.mpg), QuickTime (.mov), Audio/Video Interface (.avi) or Compuserve
GIF (.gif). Please contact the publisher about the use of other formats. Videos and computer graphics will not be accepted separately
from a manuscript that has been rejected. If the article is accepted for publication, the video will be permanently archived on the UROLOGY
website ( http://www.goldjournal.net). The location of the video on the World Wide Web will be linked in the online version
of the article.
Permission: Authors must submit written permission upon manuscript acceptance from the publisher/copyright
owner of the original source when material is reproduced from other sources. This permission must include reproduction in both print
and electronic formats for worldwide distribution.
References: References must be limited to those cited in the text,
be numbered consecutively in the order in which they are first mentioned, with their positions indicated in the text by a superscript
Arabic number. Any authors beyond three will be replaced by et al.
For journal articles: Surname and initials of
author(s), title of article, name of journal, volume: first and last pages, and year. As follows:
1. Jones CJ, Smith TH, Johnson
SV, et al: Cysts of the kidney. J Urol 33: 102-105, 1988.
For books: Surname and initials of author(s), title and subtitle,
edition (other than first). City, publishing house, year, and pages as specific reference. As follows:
1. Jones CJ, and Smith TH: Kidney Diseases, 2nd ed. Boston, Little Brown & Company, 1973, pp 50-53.
For articles or chapters in books: Surname
and initials of author(s), title of article/chapter, surname and initials of editor, title of book. City, publishing house, year, and
pages. As follows:
1. Jones CJ, and Smith TH: Value of cystography, in Roberts MD (Ed): Kidney Diseases. New York, Oxford
University Press, 1973, vol 5, pp 200-206.
References to articles in press must state journal name and year. Personal Communications
will not be included in the reference list and should be accompanied with written verification and be noted within the text.
Proofs:
To avoid publication delay, authors must return proofs within 48 hours. ALL authors must review and approve the proofs before returning
them to Elsevier. Changes will not be allowed after proofs are approved by the authors. Accepted manuscripts can be tracked at: http://authors.elsevier.com/trackpaper.html
using the Elsevier manuscript number provided in the proofs email.
Responsibility: Manuscripts will be accepted for consideration
with the understanding that they are contributed solely to UROLOGY, have never before been published, nor submitted simultaneously
elsewhere, and become the property of the publisher. The publisher is not responsible for the loss of manuscripts through circumstances
beyond its control.
Manuscripts are subject to editorial modification to bring them into conformity with the style of the journal.
Statements in articles or opinions expressed by any contributor in any article, including changes made by the copy editor, are not the
responsibility of the editors or the publishers.
Updated July 2010
|
| |
|
